TKNO Stock Analysis: Buy, Sell, or Hold?

TKNO - Alpha Teknova, Inc. Common Stock

IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
$2.71
-0.12 (-4.24%) ▼
5d: -2.87%
30d: +18.86%
90d: -32.08%
BUY
MODERATE Confidence
Analysis Updated: Mar 27, 2026 12:00 AM ET
Earnings: May 14, 2026

Get Alerted When TKNO Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
💡 BUY OPPORTUNITY: TKNO shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.

In-depth Analysis How we analyze

Valuation Analysis: TKNO is currently trading at $2.71, which is considered slightly high relative to its 30-day fair value range of $2.22 to $2.86.

Technical Outlook: Technically, TKNO is in a strong downtrend. Immediate support is located at $2.55, while resistance sits at $3.22. Short-term momentum is weak, with the stock down 4.2% recently.

Market Sentiment: TKNO has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $9.00 (+232.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position SLIGHTLY HIGH
Fair Price Range $2.22 - $2.86
Company Quality Score 55/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 73.7%

All Signals

  • BULLISH: Strong technical setup (60/100)
  • BULLISH: High volume confirmation
  • BEARISH: Downward momentum (-4.2%)
  • BULLISH: Trading 232.1% below Wall St target ($9.00)

Fair Price Analysis

30-Day Fair Range $2.22 - $2.86
Current vs Fair Value SLIGHTLY HIGH

Support & Resistance Levels

Support Level $2.55
Resistance Level $3.22
Current Trend Strong Downtrend
Technical data as of Mar 27, 2026

Fundamental Context

Forward P/E (Next Year Est.) -8.69
Wall Street Target $9.00 (+232.1%)
Revenue Growth (YoY) 7.8%
Profit Margin -42.6%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: March 30, 2026 8:56 AM ET
Data refreshes hourly during market hours. Next update: 9:56 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Stephen Gunstream BUY 26000 shares 2026-03-06

Unlock Insider Activity

See real-time buying/selling by company executives for TKNO.

Create Free Account

Already have an account? Log In

Top Rated Drug Manufacturers - Specialty & Generic Stocks

Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
NBIX
Neurocrine Biosciences I…
STRONG BUY
25 analysts
$178 62 BUY
ZTS
Zoetis Inc
STRONG BUY
19 analysts
$151 55 HOLD
LNTH
Lantheus Holdings Inc
STRONG BUY
13 analysts
$91 57 HOLD
BCRX
BioCryst Pharmaceuticals…
STRONG BUY
12 analysts
$21 60 HOLD
HCM
HUTCHMED DRC
STRONG BUY
14 analysts
$21 58 HOLD

More Analysis for TKNO

TKNO Technical Chart TKNO Price Prediction TKNO Earnings Date TKNO Investment Advisor TKNO Fair Price Analyzer TKNO Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals